Advancing Diagnostics Through Innovative Technologies.

Join Waters at the MSACL 2026, hosted by The Association for Mass Spectrometry & Advances in the Clinical Lab, as we showcase how our innovations in clinical diagnostics can help laboratories improve efficiency, enhance diagnostic confidence, and advance patient care. 

Experience Our Innovation Showcase

  • Discover the new Xevo™ TQ Absolute XR IVD Mass Spectrometer along with other innovations including the MassTrak™ Immunosuppresants Kit IVD with FDA 510(k)-cleared LC-MS/MS assay for tacrolimus quantification to support transplant patient care
  • Explore Waters Academy-Clinical, a training platform that provides onboarding, training, and ongoing education for your laboratory staff using Waters LC-MS/MS systems
  • Expert insights from Waters scientists and product specialists 

 

Waters Petite Suite Sessions

Wednesday, October 7 | 11:30am-12:45pm
Thursday, October 8 | 7:45am-8:45am
Outremont 4

Talk Title: Maximizing Column Lifetime Through Improved Contamination Management

Guy Boisvert

Clinical & Forensics Chemistry Account Manager

Waters Advanced Diagnostics

Wednesday, October 7 | 5:00pm-6:30pm
Thursday, October 8 | 12:15pm-1:15pm
Outremont 4

Talk Title: Robust by Design: Mastering Method Robustness with Smart Pre-MS1 Filtering and Chromatographic Strategies

David Farrell

Senior Scientist

Waters Advanced Diagnostics

Dominic Foley

Consulting Scientist

Waters Advanced Diagnostics

Waters Industry Breakfast Workshop:
Expanding the Boundaries of LC-MS/MS

October 7 | 8:00am-9:00am | Montreal 4

John Rudan, MD FRCCPS

Kingston General Hospital

Talk Title: Doctor, Did You Get it All? Mass Spectrometry in the Operating Room; Adding a New Dimension to the Surgeon's Field of Vision

Christiane Auray-Blais, LL.M., Ph.D.

Université de Sherbrooke

 

Talk Title: Mass Spectrometry Strategies for Translational Research: From Biomarker Discovery to Clinical Applications

Scientific Posters

Visit our poster presentations to learn more about the latest advancements in LC-MS/MS applications.

P-63 - Wednesday, October 7 9:15am EDT - Enhanced Ultra Sensitive Measurement of Serum Estrogens Using the Xevo TQ Absolute XR with UHPLC MS/MS for Clinical Research Applications
Dominic Foley

P-79 - Wednesday, October 7 - 9:15am EDT - LC‑MS/MS Measurement of Infliximab, Adalimumab, Ustekinumab, Vedolizumab and Anti‑Drug Antibodies Using mAbXmise Kits on the Xevo TQ Absolute XR MS for Clinical Research
Frank Kero

P-85 - Wednesday, October 7 9:15am EDT - Troubleshooting an Intact Peptide IP-LC-MS/MS Clinical Research Method for Amyloid-βeta Quantification in Human Plasma. A Sticky Issue!
John Vukovic

P-63 - Thursday, October 8 10:00am EDT - Long Run LC–MS/MS Robustness in Plasma: a 30,000-Injection Evaluation of Quantitative Stability, Carryover, and Uptime on a Triple Quadrupole System for Clinical Research
David Farrell

We Look Forward to Seeing You at MSACL 2026

Join us at Booth #21 as we celebrate the next chapter of LC-MS/MS diagnostic innovation and demonstrate how Waters is helping laboratories transform diagnostic workflows, improve efficiency, and advance patient care.